摘要
目的探讨分析胺碘酮在急性冠脉综合征的治疗中的临床应用。方法急性冠脉综合征伴房颤发作患者23例,在房颤发生时均给予首剂胺碘酮(3～5)mg/kg治疗。结果 23例患者中17例(73.91%)转复为窦性心律。用药前后的心电图检测指标及血压的变化差异无统计学意义(P>0.05);心室率用药前后比较差异有统计学意义(P<0.05)。心功能转复率Ⅰ、Ⅱ级复率(17/19)89.47%,Ⅲ、Ⅳ级复率(1/4)25.0%。结论胺碘酮治疗急性冠脉综合征疗效安全可靠。
Objective To explore the analysis of the clinical application of amiodarone in the treatment of acute coro- nary syndrome. Methods Acute coronary syndrome,23 patients with atrial fibrillation,atrial fibrillation were given the first dose amiodarone （3-5） mg/kg treatment. Results Of 23 patients, 17 patients（73.91%） conversion to sinus rhythm. Ventricular rate before and after treatment the difference was statistically significant （P 〈 0.05）. Conclusion Amiodarone acute coronary syndrome efficacy is safe and reliable.
出处
《中国现代医生》
2013年第2期153-154,共2页
China Modern Doctor
关键词
胺碘酮
急性冠脉综合征
Amiodarone
Acute coronary syndrome
